Bausch Health’s Strategic Growth in Latin...

By HEOR Staff Writer

January 8, 2026

Navigating Growth in Latin American Pharmaceuticals In the Latin American pharmaceuticals sector, Bausch Health is strategically expanding its footprint under the leadership of Vic...
2025 China Drug Catalog Boosts Access with 114 New Drugs and Innovative Solut...
Advancements in Continuous Glucose Monitoring for Type 2 Diabetes Management
Eloralintide Obesity Treatment: Phase 2 Trial Reveals Significant Weight Loss...
Navigating Novo Nordisk Board Changes: Leadership for Growth and Strategy
Sanofi Insulin Savings: Your Comprehensive Guide for 2025
Addressing GLP-1 Access Inequity: Lessons from HIV/AIDS Mobilization
Oral Semaglutide Benefits: EMA Approves First Oral GLP-1 RA with Cardiovascul...
Insights on GLP-1 Therapy in Bariatric Surgery Patients
Evolving Strategies in Type 2 Diabetes Management: NICE Guideline Update 2025
Building a Better Ecosystem for Digitally Enabled Diabetes Care in Europe
Comprehensive Review of Type 2 Diabetes Treatment and Diagnosis Strategies
T1 Diabetes Care with an Implantable Glucose Device